Literature DB >> 616040

Effect of Verapamil on pancreatic glucagon release from the isolated, perfused canine pancreas.

K Hermansen, J Iversen.   

Abstract

The effect of Verapamil, a potent calcium antagonist, upon pancreatic glucagon release was investigated in the isolated, perfused canine pancreas. Verapamil at concentrations ranging between 10(-5)-10(-4) mol/l caused a dose-related inhibition of glucagon release at a glucose concentration of 25 mg/dl. The inhibition was an immediate and reversible phenomenon. The inhibitory effect was reduced when the Ca2+ concentration was increased from 1.3 to 5.0 mmol/l. The results are compatible with earlier findings from our laboratory demonstrating that calcium plays a key role in the stimulus-secretion coupling of glucagon release.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 616040     DOI: 10.3109/00365517709156068

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  8 in total

1.  Calcium, glucose and glucagon release.

Authors:  J Iversen; K Hermansen
Journal:  Diabetologia       Date:  1977-08       Impact factor: 10.122

2.  Dual action of mn++ upon the secretion of insulin and glucagon from the isolated, perfused canine pancreas. Possible interactions with ca++.

Authors:  K Hermansen; J Iversen
Journal:  Diabetologia       Date:  1978-12       Impact factor: 10.122

Review 3.  Effects of antihypertensive drugs on endocrine function.

Authors:  E P Brass
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

4.  Influence of short term verapamil treatment on glucose metabolism in patients with non-insulin dependent diabetes mellitus.

Authors:  M Busch Sørensen; H Sjøstrand; H Sengeløv; M Tiefenthal Thrane; J Juul Holst; J Lyngsøe
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  Characterisation of somatostatin release from the pancreas: the role of calcium and acetylcholine.

Authors:  K Hermansen; S E Christensen; H Orskov
Journal:  Diabetologia       Date:  1979-04       Impact factor: 10.122

6.  Modulation by verapamil of insulin and glucagon secretion in man.

Authors:  D Giugliano; S Gentile; M Verza; N Passariello; G Giannetti; M Varricchio
Journal:  Acta Diabetol Lat       Date:  1981 Apr-Jun

7.  Haloperidol, a dopaminergic antagonist: somatostatin-like inhibition of glucagon and insulin release from the isolated, perfused canine pancreas.

Authors:  K Hermansen
Journal:  Diabetologia       Date:  1978-10       Impact factor: 10.122

Review 8.  [Calcium antagonists in the therapy of hypertension].

Authors:  A Heidland; E Heidbreder; W H Hörl; R M Schäfer
Journal:  Klin Wochenschr       Date:  1983-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.